The purpose of this study is to evaluate the safety and effectiveness of an investigational medication compared to placebo (an inactive substance) for the treatment of symptoms associated with endometriosis in women aged 18 to 49 years.

Duration of Study - Approximately 38 weeks

Participants - Women aged 18 to 49 years

Study procedures include - Study related exams, laboratory tests, and investigational medication or placebo at no cost to you

Participant Stipend - Compensation for time and travel may be available

• Must be aged 18 to 49 years
• Must have a surgical diagnosis (laparoscopy) of endometriosis within the last 8 years
• Must not be pregnant or breastfeeding

If You Meet All of the Above Criteria:

You may be a candidate to participate in this study! Please take the first step by clicking below.

Interest Form

If You Don't Meet the Above Criteria:

You may qualify for one of our future studies.  Please take the first step by clicking below.

Interest Form